Primary aldosteronism - a multidimensional syndrome.
Turcu AF, Yang J, Vaidya A.
Nat Rev Endocrinol. 2022 Nov;18(11):665-682. doi: 10.1038/s41574-022-00730-2. Epub 2022 Aug 31.
Pathogenesis and treatment of primary aldosteronism.
Zennaro MC, Boulkroun S, Fernandes-Rosa FL.
Nat Rev Endocrinol. 2020 Oct;16(10):578-589. doi: 10.1038/s41574-020-0382-4. Epub 2020 Jul 28.
Primary Aldosteronism: JACC State-of-the-Art Review.
Rossi GP.
J Am Coll Cardiol. 2019 Dec 3;74(22):2799-2811. doi: 10.1016/j.jacc.2019.09.057.
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
Vaidya A, Carey RM.
J Clin Endocrinol Metab. 2020 Dec 1;105(12):3771-83. doi: 10.1210/clinem/dgaa606.
Primary Aldosteronism: Novel Insights.
Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, Doumas M.
Curr Hypertens Rev. 2020;16(1):19-23. doi: 10.2174/1573402115666190415155512.
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.
Vaidya A, Mulatero P, Baudrand R, Adler GK.
Endocr Rev. 2018 Dec 1;39(6):1057-1088. doi: 10.1210/er.2018-00139.
Primary Aldosteronism.
Quencer KB, Rugge JB, Senashova O.
Am Fam Physician. 2023 Sep;108(3):273-277.
Subclinical primary aldosteronism.
Parisien-La Salle S, Brown JM, Tsai CH, Hundemer GL, Vaidya A.
Arch Endocrinol Metab. 2025 Nov 28;70(Spec 1):e250400. doi: 10.20945/2359-4292-2025-0400.
Primary Aldosteronism: Where Are We Now? Where to from Here?
Funder JW.
Horm Metab Res. 2020 Jun;52(6):459-466. doi: 10.1055/a-1120-8623. Epub 2020 May 4.
Primary Aldosteronism: Where Are We Now? Where to From Here?
Funder JW, Carey RM.
Hypertension. 2022 Apr;79(4):726-735. doi: 10.1161/HYPERTENSIONAHA.121.18761. Epub 2022 Jan 24.
